Fundación Progreso y Salud

Recent papers from Fundación Progreso y Salud

1. Utility models and health technology: patterns of use and decision criteria in Spain, Germany and Japan (2015–2026)2026
2. Menopause-driven metabolomic shifts: unravelling cardiovascular disease risk in womenEndocrine Reviews · 2026
3. A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug RepurposingInternational Journal of Molecular Sciences · 2026
4. Methods used to design audit and feedback interventions to change clinical practice: a scoping reviewFrontiers in Health Services · 2026
5. Co-Creative Processes for the Circular Management of Solid Waste Through Digital Twins: A Framework for Progreso, Hidalgo, MexicoWaste · 2026
6. The PRECISE framework: a structured approach to antibiogram interpretation for antimicrobial optimization at the bedsideRevista Española de Quimioterapia · 2026
7. 1 H HR‐MAS NMR Metabolomics in Combination With Transcriptomic Correlation Provides New Insights Into Metabolic Heterogeneity Across Breast Cancer Immunohistochemical SubtypesNMR in Biomedicine · 2026
8. Comprehensive evaluation of AlphaFold/OpenFold prediction of experimentally unresolved proteins through novel metricsBriefings in Bioinformatics · 2026
9. Service User Perceptions of Addiction Treatment Services in Barcelona: Barriers, Gender, Stigma, Employment, and Recommendations for ImprovementNordic Studies on Alcohol and Drugs · 2026
10. Urinary Organic Acid Profiling by GC-MS Reveals Distinct Metabolic Signatures for Non-Invasive Diagnosis and Disease Activity Monitoring of Inflammatory Bowel DiseaseInternational Journal of Molecular Sciences · 2026
11. Association between glycated hemoglobin and lipid parameters at the time of type 2 diabetes mellitus diagnosis: evidence from a regional populationFrontiers in Medicine · 2026
12. Bridging preclinical development and clinical manufacturing: a translational GMP-Platform for lentiviral vector production in academic CAR T-Cell therapyJournal of Translational Medicine · 2026
13. Environmental Pollutants and Neuroinflammation in Alzheimer’s Disease ProgressionJournal of dementia and Alzheimer's disease · 2026
14. Changes in Resting Energy Expenditure in Response to Different Dietary Patterns: A Randomized Clinical Trial Exploratory Sub-AnalysisNutrients · 2026
15. Emerging Perspectives on How Metallic Nanoparticles and Their Oxide Forms Interact with the Tumor MicroenvironmentProcesses · 2026
16. Safety and efficacy of convalescent plasma for COVID-19 in the pre-vaccine era, and implementation in a large healthcare system: A phase I/II randomized, multicentre clinical trial (PC-COVID)Enfermedades infecciosas y microbiologia clinica (English ed ) · 2026
17. Menopause age and hypercholesterolemia comorbidities: a region-wide retrospective cohort study in Andalusia, Spain (2016–2022)BMJ Open · 2026
18. Recurrent t(9;12) translocation disrupting ACVRL1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated familiesEuropean Journal of Internal Medicine · 2026
19. Food-Derived Antihypertensive Peptides: Mechanisms, Multi-Methodological Approaches, Bioavailability, and Functional Food ApplicationsMolecules · 2026
20. FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastomaENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026